| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/24/2008 | US20080096861 Chemical Compounds |
| 04/24/2008 | US20080096857 Photodynamic Therapy For The Treatment Of Hyperactive Sebaceous Gland Disorders Using Topically Applied Hydrophobic Green Porphyrins |
| 04/24/2008 | US20080096828 7-Quinolyl ketolide antibacterial agents |
| 04/24/2008 | US20080096792 polypeptides used as wound healing agents, tissue regeneration, inhibition of cancer metastesis mediated by extracellular matrix protein including laminin |
| 04/24/2008 | US20080095870 active extracts of atractylodes lancea, semen coicis, and phellodendron amurense rupr |
| 04/24/2008 | US20080095866 Topical Compositions Containing Phosphorylated Polyphenols |
| 04/24/2008 | US20080095773 Polypeptides homologous to vegf and bmp1 |
| 04/24/2008 | US20080095766 Methods for the Treatment of Autoimmune Disorders Using Immunosuppressive Monoclonal Antibodies with Reduced Toxicity |
| 04/24/2008 | US20080095762 Glycoprotein compositions |
| 04/24/2008 | US20080095735 Skin-Protective Polymer For Use In Teat Care Compositions |
| 04/24/2008 | US20080095722 Extended Surface Aggregates in the Treatment of Skin Conditions |
| 04/24/2008 | DE202007004981U1 Zusammensetzung, insbesondere für die topische Behandlung von Hauterkrankungen Composition, particularly for topical treatment of skin diseases |
| 04/24/2008 | DE102006051035A1 Dermatological composition for use in cosmetics or medicine, e.g. for combating decubitus or gangrene, contains photocatalyst, e.g. zinc oxide, to degrade skin or wound contaminants |
| 04/24/2008 | DE102006049929A1 Filmbildende Gelkomposition zur Wund- bzw. Hautpflege The film-forming gel composition for wound and skin care |
| 04/24/2008 | DE102006049675A1 Hautfreundliche W/O-Emulsionen Skin-friendly W / O emulsions |
| 04/24/2008 | DE102006049672A1 Hautfreundliche W/O-Emulsionen Skin-friendly W / O emulsions |
| 04/24/2008 | DE102006049580A1 Topische Zusammensetzung zur Behandlung von Ekzemen A topical composition for treatment of eczema |
| 04/24/2008 | DE102006049185A1 Verwendung von Deuteriumdioxid zur Behandlung von hyperproliferativen Erkrankungen der Haut Use of Deuteriumdioxid for the treatment of hyperproliferative skin disorders |
| 04/24/2008 | CA2666603A1 Therapeutic pyrazolyl thienopyridines and uses thereof for treating tgf.beta. mediated conditions |
| 04/23/2008 | EP1914310A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/23/2008 | EP1914301A1 Anti-CD80 antibodies |
| 04/23/2008 | EP1913948A1 Re-epithelializing pharmaceutical compositions containing xanthan gum |
| 04/23/2008 | EP1913012A2 Oligomers of cholesterol, cholesterol sulfate and cholesterol esters, and medicaments containing the same |
| 04/23/2008 | EP1912964A2 Dihydroxyanthraquinones and their use |
| 04/23/2008 | EP1912646A2 Combinations containing ikk-beta inhibitors |
| 04/23/2008 | EP1912641A2 Methods and compositions containing natural folates for protecting against radiation damage |
| 04/23/2008 | EP1675557B1 Composition comprising a sesquiterpene lactone |
| 04/23/2008 | EP1488797B1 Oral preprations having itching-relieving or antipruritic activity |
| 04/23/2008 | EP1333834B1 Antiinflammation agents |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | EP1238071B1 Uncharged antisense oligonucleotides targeted to bacterial 16s and 23s rrnas and their uses |
| 04/23/2008 | EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/23/2008 | EP1214398B1 Chimeric virus-like particles or chimeric capsomers from bpv |
| 04/23/2008 | EP1061962B1 Disposable absorbent article having a skin care composition containing an enzyme inhibitor |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/23/2008 | EP0975739B1 Stimulation, culture and preservation of pancreatic and other cells |
| 04/23/2008 | CN101166762A Albumin-fused Kunitz domain peptides |
| 04/23/2008 | CN101166535A Dermatologic use of milk proteins |
| 04/23/2008 | CN101166510A External preparation for skin |
| 04/23/2008 | CN101164620A External preparation for skin |
| 04/23/2008 | CN101164617A Combination drug therapy for reducing scar tissue formation |
| 04/23/2008 | CN101164609A Method for preparing spraying agent for treating smelly feet and beriberi |
| 04/23/2008 | CN101164600A Medicine for treating acne and whelk |
| 04/23/2008 | CN101164590A Traditional Chinese medicine orally administered cream for leveling scar, eliminating striae gravidarum and wrinkle, and preparation method |
| 04/23/2008 | CN101164575A Method for preparing spraying agent for treating seasonal dermatitis |
| 04/23/2008 | CN101164574A Medicine for treating burns and scalds and its preparation method |
| 04/23/2008 | CN101164565A Quick-effective traditional Chinese medicine for treating beard and hair small and white, early white and alopecia in aged, and preparation method |
| 04/23/2008 | CN101164549A External-applied medicine for treating acne and manufacturing method thereof |
| 04/23/2008 | CN101164539A New use of staurosporine derivatives |
| 04/23/2008 | CN101164517A Use of benzodihydropyran derivatives in cosmetic or dermatology preparations |
| 04/23/2008 | CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives |
| 04/23/2008 | CN100383139C Piperidine-2,6-dione derivatives capable of inhibiting cell from releasing tumor necrosis factor |
| 04/23/2008 | CN100382836C External use traditional Chinese medicinal preparation for treating ringworm of the nails |
| 04/23/2008 | CN100382835C Disinfectant liquid for treating hand/foot tinea |
| 04/23/2008 | CN100382831C Eczema treating Chinese medicine preparation |
| 04/23/2008 | CN100382803C Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid |
| 04/23/2008 | CN100382783C Psoralea drip pill and its preparation method |
| 04/23/2008 | CN100382781C Method for preparing bath powder of Tibet medicine and its quality control method |
| 04/22/2008 | US7361787 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent |
| 04/22/2008 | US7361758 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 04/22/2008 | US7361685 Compounds for use in the treatment of skin conditions |
| 04/22/2008 | US7361664 For therapy of cancer, hyperparathyroidism, vascular calcification, bone disease, renal failure or kidney stones, psoriasis |
| 04/22/2008 | US7361463 Degradation resistant antihypoxic agents for use in treatment and prevention of hypoxia and ischemic related tissue damage |
| 04/22/2008 | US7361373 Carbonized pine cone for treating burns; non-scarring; reduced side effects |
| 04/22/2008 | US7361362 Emulsion composition |
| 04/22/2008 | US7361356 Gene expression in host cell of conformational epitopes; used as elements of diagnostic immunoassay procedures for papillomavirus infection |
| 04/22/2008 | US7361340 Specifically recognizing human oculospanin and having cytotoxic activity against cancer cells, cancer therapy |
| 04/22/2008 | CA2400447C Kinase inhibitors |
| 04/22/2008 | CA2276661C Personal wash liquid composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers |
| 04/22/2008 | CA2265993C Novel antimicrobial cosmetic compositions |
| 04/22/2008 | CA2259781C Low tack lotion, gels and creams |
| 04/22/2008 | CA2174737C Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents |
| 04/22/2008 | CA2129542C Pharmaceutical preparation based on rhamnolipid |
| 04/17/2008 | WO2008046084A2 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 04/17/2008 | WO2008046065A1 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 04/17/2008 | WO2008045564A2 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008044659A1 Highly absorbable composition for oral administration containing oxidized coenzyme q10 |
| 04/17/2008 | WO2008044656A1 Imidazolidinone derivative |
| 04/17/2008 | WO2008044636A1 Anti-wrinkle agent and skin preparation for external use |
| 04/17/2008 | WO2008043974A2 Two-compartment skincare products comprising ivermectin, and uses thereof |
| 04/17/2008 | WO2008043973A1 Dermatological composition containing avermictin nanocapsules, method for preparing the same and uses thereof |
| 04/17/2008 | WO2008043944A2 Use of an active ingredient derived from flax that acts on the papillary dermis, for its anti-ageing action |
| 04/17/2008 | WO2008043856A1 New composition for improving skin quality and a process for preparing the same |
| 04/17/2008 | WO2008043263A1 Isoxazole derivatives and methods of treating diseases |
| 04/17/2008 | WO2008043175A1 SOLUBLE β-N-ACETYLGLUCOSAMINIDASE BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF |
| 04/17/2008 | WO2008024390A3 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other disorders |
| 04/17/2008 | WO2008021933A3 N-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives as prostaglandine receptor inhibitors |
| 04/17/2008 | WO2008019372A3 2-aminobenzoxazole carboxamides as 5ht3 modulators |
| 04/17/2008 | WO2008012031A3 Blockers of gsk3 for the prevention and treatment of pemphigus vulgaris |
| 04/17/2008 | WO2007146323A3 Substituted cyanopyridines as protein kinase inhibitors |
| 04/17/2008 | WO2007144493A3 Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative |
| 04/17/2008 | WO2007141224A3 Jnk inhibitors for treatment of skin diseases |
| 04/17/2008 | US20080091010 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 04/17/2008 | US20080090861 Cancer and fibrotic disorders such as scarring prevention; 2-(4-methyl-1-(6-methylpyridin-2-yl)-1H-pyrazol-5-yl)thieno[2,3-c]pyridine for example; activin receptor-like kinase-5 (ALK-5) inhibitors |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090854 Cxcr2 inhibitors |
| 04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
| 04/17/2008 | US20080090842 Novel pyridyl cyanoguanidine compounds |
| 04/17/2008 | US20080090830 thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failures and cancer |